1. Hyperpigmentation induced by topical 5-aminolaevulinic acid plus visible light
- Author
-
Alfredo Manco, Pietro Santoianni, Gaetano De Rosa, Donatella D’Onofrio, Giuseppe Roberti, Raffaele Liuzzi, Stefania Staibano, Giuseppe Monfrecola, Enrico Maria Procaccini, Monfrecola, Giuseppe, Procaccini, Em, D'Onofrio, D, Roberti, G, Liuzzi, R, Staibano, Stefania, Manco, A, DE ROSA, Gaetano, and Santoianni, P.
- Subjects
Adult ,Male ,Pathology ,medicine.medical_specialty ,Erythema ,Light ,medicine.medical_treatment ,Administration, Topical ,Biophysics ,Human skin ,Photodynamic therapy ,chemistry.chemical_compound ,Melanogenesis ,Visible light ,5-Aminolaevulinic acid ,Hyperpigmentation ,Psoriasis ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,Topical, Adult, Aminolevulinic Acid ,Hypopigmentation ,Skin ,Radiation ,administration /&/ dosage, Colorimetry, Female, Humans, Hyperpigmentation ,Radiological and Ultrasound Technology ,Protoporphyrin IX ,integumentary system ,Chemistry ,drug effects/pathology/radiation effects/ultrastructure ,Electron, Middle Aged, Photochemotherapy, Skin ,Aminolevulinic Acid ,Middle Aged ,medicine.disease ,Occlusive dressing ,Microscopy, Electron ,Photochemotherapy ,Administration ,Colorimetry ,Female ,medicine.symptom ,chemically induced/etiology, Light, Male, Microscopy - Abstract
Photodynamic therapy (PDT) with 5-aminolaevulinic acid (ALA) is an alternative tool for the treatment of superficial non-melanoma skin cancers. Recently ALA-PDT has been employed with encouraging results also for warts, condylomata and psoriasis. In this study the effects of topical ALA plus irradiation with visible light on intact human skin have been evaluated. Five skin areas (A, B, C, D, and E) on the inner upper part of the arms of five healthy volunteers (skin types III and IV) were treated with (A) ALA 20% in base cream without irradiation, (B) only the vehicle (base cream) without ALA, (C, D and E) ALA cream at the concentrations of 5, 10 and 20%, respectively; all treatments were applied with an occlusive dressing. Four hours after ALA or vehicle application areas B, C, D and E were irradiated with a fixed dose of 40 J/cm 2 . ALA penetration through the intact skin was evaluated by in vivo fluorescence determination. The effects on healthy skin were evaluated by clinical and chromometric examinations, light microscopy, immunohistochemistry and electron microscopy. Results: (1) in vivo fluorescence demonstrated that ALA is able to penetrate through the intact skin, when applied with occlusive dressing and induces a classical fluorescence peak due to Protoporphyrin IX (PpIX) formation, which is the active photosensitiser. (2) Skin areas receiving ALA plus irradiation showed erythema and swelling just after the irradiative session and hyperpigmentation 48–72 h later. (3) Colourimetric data confirmed significant skin colour changes: values a * (representing the erythematous changes) increased only on the skin areas where ALA+irradiation were applied and during the 48 h after irradiation, thereafter a * began to decrease; values L * (pigmentation) increased during the 2 weeks following treatment. (4) Histopathological, immunohistochemical (S100, HMB-45) and electron microscopic findings showed an absolute increment of the number of melanocytes, which appeared clearly activated. In conclusion the application of ALA cream followed by irradiation is able to induce a pigmentation response in healthy human skin, at least in skin types III and IV. This melanocytic activation could have a potential for the treatment of skin disorders characterised by hypopigmentation.
- Published
- 2002